GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Procaps Group S.A.
Procaps is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules. Its share price reflects both the growth of the regional pharmaceutical market and its expertise in niche drug delivery technologies.
Share prices of companies in the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company that develops and manufactures soft gelatin capsules and other innovative drug delivery systems. We classified it in the "Other Pharmaceuticals" category. The chart below shows how investors value pharmaceutical companies in emerging markets.
Broad Market Index - GURU.Markets
Procaps Group is a Latin American pharmaceutical company that develops and manufactures soft gelatin capsules and other innovative drug delivery systems. We classified it in the "Other Pharmaceuticals" category. The chart below shows how investors value pharmaceutical companies in emerging markets.
Change in the price of a company, segment, and market as a whole per day
PROC - Daily change in the company's share price Procaps Group S.A.
For Procaps Group S.A., a Latin American pharmaceutical company, daily volatility reflects sensitivity to regional market conditions. This metric is an indicator of demand for its products and contract manufacturing services.
Daily change in the price of a set of shares in a market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company that develops and manufactures soft gelatin capsules and other dosage forms. The pharmaceutical market in emerging markets offers significant potential, but also risks. The chart below illustrates the volatility in this sector, helping to evaluate PROC.
Daily change in the price of a broad market stock, index - GURU.Markets
Procaps is a Latin American pharmaceutical company. Its US-listed shares bring the dynamics of the emerging market pharmaceutical sector to the market. These international factors complicate the overall market volatility picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Procaps Group S.A.
Procaps Group S.A.'s year-over-year performance tells the story of its role as a contract manufacturing organization (CDMO) in Latin America. Its market capitalization growth over the past 12 months reflects demand for its unique softgel capsule technology, as well as its success in selling its own pharmaceutical brands in this rapidly growing market.
Annual dynamics of market capitalization of the market segment - Pharma other
Procaps is a Latin American pharmaceutical company specializing in the development and production of complex dosage forms. This chart shows how its technological expertise, focus on emerging markets, and acquisition strategy influence its performance compared to the global pharmaceutical industry.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Procaps, a contract drug manufacturer in Latin America, is an "infrastructure" bet on the regional pharmaceutical industry. Its performance relative to the market is a barometer of the sector's health. The growth of local biotech leads to increased orders and allows it to grow alongside the industry.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Procaps Group S.A.
Procaps is a Latin American pharmaceutical company. Its monthly performance reflects both sales of its own products and revenue from contract manufacturing for other companies. Growth in Latin American markets is key.
Monthly dynamics of market capitalization of the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. The graph below illustrates the overall dynamics in the pharmaceutical sector, highlighting the importance of technologies that improve the properties and ease of administration of medications.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Latin American pharmaceutical stocks follow the rhythm of their regional economies and healthcare systems. The chart below shows the dynamics of global markets. How much does Procaps Group S.A.'s path deviate from this general trend?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Procaps Group S.A.
Procaps, a Latin American pharmaceutical company, shares weekly reflect the state of healthcare in the region. Price movements reflect demand for its products and the company's ability to expand its presence in emerging markets.
Weekly dynamics of market capitalization of the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules. This chart compares its performance with the pharmaceutical sector to assess the impact of regional markets and its technological specialization.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Procaps is a pharmaceutical company. Its success depends on the commercialization of its products. This chart will help you understand: does Procaps' stock live its own life, reacting to sales volumes and news, or does the overall dynamics of the pharmaceutical sector and the market determine its trend?
Market capitalization of the company, segment and market as a whole
PROC - Market capitalization of the company Procaps Group S.A.
Procaps' market capitalization tells the story of a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules. Its post-SPAC chart reflects both the region's growth potential and the economic and currency risks associated with doing business in Latin America.
PROC - Share of the company's market capitalization Procaps Group S.A. within the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical manufacturer. Its share of the global pharmaceutical industry market capitalization is small, but significant at the regional level. The chart illustrates how the market views its production capabilities and growth potential beyond its home market.
Market capitalization of the market segment - Pharma other
Procaps is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other drug delivery technologies. The chart below shows the overall market capitalization of this sector. Its dynamics provide the backdrop against which Procaps provides its services to other pharmaceutical companies.
Market capitalization of all companies included in a broad market index - GURU.Markets
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of complex dosage forms. Its market capitalization reflects the growth of the pharmaceutical market in developing countries. Its performance on the overall chart demonstrates how local champions are becoming global players.
Book value capitalization of the company, segment and market as a whole
PROC - Book value capitalization of the company Procaps Group S.A.
Procaps' book value lies in its modern factories in Latin America producing soft gelatin capsules and other pharmaceutical products. This represents real, technological, and production capital, and is an important contract manufacturer. How has this asset changed? The chart below shows its dynamics.
PROC - Share of the company's book capitalization Procaps Group S.A. within the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company that produces soft gelatin capsules and other medications at its own facilities. The chart shows the share of this production capacity in the pharmaceutical sector, reflecting its technological leadership and physical scale.
Market segment balance sheet capitalization - Pharma other
Procaps, a contract manufacturer for the pharmaceutical industry, is a highly capital-intensive business. It requires the ownership of sterile production facilities. The BCap_Seg sector chart demonstrates how demanding and demanding this industry is.
Book value of all companies included in the broad market index - GURU.Markets
Procaps' balance sheet consists of its advanced manufacturing facilities in Latin America, where it produces soft gelatin capsules and other complex dosage forms for pharmaceutical companies worldwide. Its assets include its unique production technologies and capacities. The chart shows the physical weight of this major contract manufacturer.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Procaps Group S.A.
Procaps Group is a pharmaceutical company specializing in the development of complex dosage forms (e.g., softgels). Its balance sheet consists of manufacturing plants and technologies. Its market capitalization is a premium on its unique expertise and patents, which enable it to improve existing drugs.
Market to book capitalization ratio in a market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of advanced dosage forms, such as soft gelatin capsules. Its valuation on the chart reflects its technological expertise and position in emerging markets.
Market to book capitalization ratio for the market as a whole
Procaps Group S.A., a pharmaceutical company, possesses both production facilities and intellectual property in the form of technologies and brands. This chart helps understand how the market balances valuation between tangible assets and growth potential in the pharmaceutical sector.
Debts of the company, segment and market as a whole
PROC - Company debts Procaps Group S.A.
Procaps Group, a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules, is using debt to expand its production capacity and pursue international expansion. This chart shows how the company is investing in its unique technologies and aiming to become a global partner for the pharmaceutical industry.
Market segment debts - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative dosage forms. This chart shows how the company funds its R&D and manufacturing capacity to serve both regional and international markets.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules. This chart illustrates how the company uses debt to expand its production capacity and enter new markets, allowing us to assess its growth strategy and financial risks.
Market segment debt to market segment book capitalization - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules (softgels). The chart shows the overall debt burden in the pharmaceutical industry, providing context for assessing how Procaps is funding its technological development and expansion into new markets.
Debt to book value of all companies in the market
Procaps Group S.A., a pharmaceutical company specializing in the development and production of soft gelatin capsules, requires investment in technology and production capacity. This chart, showing the overall market debt burden, provides context. It helps assess how the company is funding its innovation and expansion in global markets.
P/E of the company, segment and market as a whole
P/E - Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart shows how the market perceives its technological leadership in the region. The dynamics reflect the growth of the Latin American pharmaceutical market.
P/E of the market segment - Pharma other
Pharmaceutical manufacturing, where Procaps is a major contract manufacturer in Latin America, is a significant sector. This chart shows the average valuation for pharmaceutical companies. It helps to understand that Procaps is valued based on its manufacturing capabilities and long-term contracts with major pharmaceutical brands, as well as regional risks.
P/E of the market as a whole
Procaps is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other dosage forms. Its valuation serves as a barometer of the pharmaceutical market in Latin America. The global sentiment reflected here is less important to the company than the economic situation and healthcare systems in its home markets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Procaps Group S.A.
This chart from Procaps Group S.A., a Latin American pharmaceutical company, shows market expectations for future revenue. It reflects forecasts for growth in demand for its pharmaceuticals and contract manufacturing services, as well as its ability to expand into new markets.
%20P%2FE%20Procaps%20Group%20S.A.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Procaps-Group-S.A.&v=1772547125866 "Chart of the company's future (projected) P/E Procaps Group S.A.")
Future (projected) P/E of the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company that develops and manufactures soft gelatin capsules and other innovative drug delivery systems for itself and other pharmaceutical companies. This chart shows forecasts for the pharmaceutical industry. This helps assess how the market perceives Procaps' technological advantages and its strategy for expanding into international markets.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772547126175 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Procaps Group S.A. is a Latin American pharmaceutical company that develops and manufactures drugs. As an emerging market stock, its valuation depends on both its business performance and global interest in the region. This chart, reflecting risk appetite in the US, influences capital flows into Latin America.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772547126242 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules (softgels). Profits come from contracts with other pharmaceutical companies and sales of its own products. This chart shows the company's technological position in the global pharmaceutical market.
Profit of companies in the market segment - Pharma other
Procaps Group is a pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart, reflecting profitability in the pharmaceutical sector, demonstrates the importance of manufacturing technologies. Their expertise enables improvements to existing drugs, making them more effective and convenient for patients.
Overall market profit
Procaps Group S.A. is a Latin American pharmaceutical company that develops and manufactures specialized dosage forms, such as soft gelatin capsules. The company provides its services to other pharmaceutical companies. Demand for its technologies depends on activity in the pharmaceutical industry, which experiences stable growth independent of short-term economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of softgel capsules and other innovative drug delivery systems. This chart shows analysts' estimates of the company's growth in Latin American markets and the expansion of its contract manufacturing.
%20profit%20of%20the%20company%20Procaps%20Group%20S.A.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Procaps-Group-S.A.&v=1772547126707 "Graph of future (projected) profit of the company Procaps Group S.A.")
Future (predicted) profit of companies in the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative dosage forms. Growth depends on expansion into new markets. This chart for the pharmaceutical sector shows overall industry profitability expectations in emerging markets, which are key to Procaps.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772547126727 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Procaps Group is a Latin American pharmaceutical company that develops and manufactures medications. Its business is dependent on regional healthcare spending. This graph, reflecting global economic expectations, impacts emerging markets and the financial capacity of healthcare systems and consumers.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772547126775 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company that develops and manufactures specialized dosage forms, such as soft gelatin capsules. The chart shows how investors value its revenue. It reflects its technological leadership in its niche and growth potential in emerging markets.
P/S market segment - Pharma other
Procaps Group S.A. is a pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. The company's revenue depends on contracts with other pharmaceutical companies. This chart helps understand how the market values Procaps' technological expertise and manufacturing capabilities.
P/S of the market as a whole
Procaps Group is a Latin American pharmaceutical company that develops and manufactures specialized dosage forms, such as soft gelatin capsules. This chart, which displays overall market revenue valuation, helps understand how investors view this emerging-market-focused pharmaceutical company, given its unique opportunities and risks.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart shows how investors assess future growth in Latin American pharmaceutical markets and the demand for its technological solutions from other pharmaceutical companies.
%20P%2FS%20Procaps%20Group%20S.A.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Procaps-Group-S.A.&v=1772547126975 "The graph of the company's future (projected) P/S Procaps Group S.A.")
Future (projected) P/S of the market segment - Pharma other
Procaps Group S.A. is an integrated pharmaceutical company that develops, manufactures, and markets medications, primarily in Latin America. The company is known for its soft gelatin capsule technology. This chart shows the average estimated future sales in the pharmaceutical sector. It helps understand how the market views Procaps' position in its key markets.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772547127012 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart reflects overall investor sentiment. The company is a key player in emerging pharmaceutical markets and a partner for many global brands.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772547127094 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Procaps Group S.A.
This chart shows the sales of Procaps Group, a Latin American pharmaceutical company that develops and manufactures pharmaceuticals and nutraceuticals, often acting as a contract manufacturer. Revenue reflects demand for its products and manufacturing services from other pharmaceutical companies.
Sales of companies in the market segment - Pharma other
Procaps Group S.A. is a pharmaceutical company specializing in the development and production of soft gelatin capsules (softgels) and other innovative dosage forms. This chart reflects revenue in the pharmaceutical industry. Procaps' unique technologies enable improvements to existing drugs, which is in demand by major pharmaceutical companies worldwide.
Overall market sales
Procaps Group is a pharmaceutical company specializing in the development and production of soft gelatin capsules and other advanced dosage forms. Its growth is driven by demand for pharmaceutical products. This total revenue chart reflects the state of the healthcare sector and consumer spending on medications.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. The chart reflects analyst expectations for growth in the pharmaceutical market in Latin America.
%20sales%20of%20the%20company%20Procaps%20Group%20S.A.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Procaps-Group-S.A.&v=1772547127524 "Schedule of future (projected) sales of the company Procaps Group S.A.")
Future (projected) sales of companies in the market segment - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart shows the forecast for the entire pharmaceutical market, where Procaps technologies help improve existing drugs and create new ones.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772547127555 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Procaps Group is a Latin American pharmaceutical company that develops and manufactures specialized dosage forms, such as soft gelatin capsules. This chart, reflecting general trends in global healthcare, provides the backdrop, but the company's growth depends more on its ability to secure contracts with major pharmaceutical brands and expand into new markets.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772547127601 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Procaps Group S.A.
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. Its profitability depends on contract manufacturing volumes and sales of its own brands. This chart shows how the company monetizes its unique technological know-how in the pharmaceutical industry.
Market segment marginality - Pharma other
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. Profitability depends on technological leadership and contract manufacturing for other pharmaceutical companies. This chart shows the operational efficiency of their specialized pharmaceutical technology.
Market marginality as a whole
Procaps Group is a Latin American pharmaceutical company that develops and manufactures specialized dosage forms, such as soft gelatin capsules. They operate both in-house and contract brands. This overall profitability chart is important to them because it reflects the overall state of the pharmaceutical market and their partners' willingness to invest in new products.
Employees in the company, segment and market as a whole
Number of employees in the company Procaps Group S.A.
Procaps Group is a pharmaceutical company specializing in the development and manufacturing of complex dosage forms (CDMO). Its extensive staff operates state-of-the-art manufacturing facilities. This chart reflects its production capacity and its role as a key partner for global pharmaceutical companies.
Share of the company's employees Procaps Group S.A. within the market segment - Pharma other
Procaps Group is a pharmaceutical company specializing in the development and production of complex dosage forms, such as soft gelatin capsules. This chart reflects its production capacity. It shows the proportion of specialists in this segment of the pharmaceutical industry employed at its plants to produce innovative products.
Number of employees in the market segment - Pharma other
Procaps Group S.A. is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. This chart reflects employment trends in the pharmaceutical sector. The growing number of technologists and engineers in the sector indicates high demand for advanced drug production technologies.
Number of employees in the market as a whole
Procaps Group is a Latin American pharmaceutical company that develops and manufactures medications. Its growth depends on the state of healthcare systems and the purchasing power of the region's population. Global economic trends, reflected in this chart, influence the overall economic environment, which impacts the markets in which Procaps operates.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Procaps Group S.A. (PROC)
Procaps Group S.A. is a Latin American pharmaceutical company specializing in the development and production of softgels and other complex dosage forms. It is a CDMO (commercial manufacturing organization). The chart shows how much the market values their manufacturing know-how and patents. The high cost per employee reflects that they are not just a "factory," but an R&D center and manufacturer of high-margin products.
%20of%20the%20company%20Procaps%20Group%20S.A.%20(PROC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Procaps-Group-S.A.-PROC&v=1772547128018 "Chart of market capitalization per employee (in thousands of dollars) of the company Procaps Group S.A. (PROC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Procaps Group is a pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative drug delivery systems. It is a technologically advanced manufacturing company. This chart shows how the market values its manufacturing know-how and intellectual property in this specific pharmaceutical niche.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772547128024 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Procaps Group is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules. The chart shows its valuation within the pharmaceutical industry. It reflects how the team creates value through its unique technology and production capabilities, serving customers worldwide.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772547128049 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Procaps Group S.A. (PROC)
Procaps is a Latin American pharmaceutical company. They specialize in the development and production of complex dosage forms, primarily softgels (soft gelatin capsules), both for themselves and for other companies (CDMOs). This chart demonstrates the efficiency of their factories and R&D, as well as their ability to produce high-margin products.
%20Chart%20Procaps%20Group%20S.A.%20(PROC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Procaps-Group-S.A.-PROC&v=1772547128171 "Company Profit Per Employee (in thousands of dollars) Chart Procaps Group S.A. (PROC)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Procaps is a Latin American pharmaceutical company specializing in the development and production of soft gelatin capsules (softgels) for both its own brands and contract manufacturers. This metric reflects the efficiency of its CDMO manufacturing facilities and the profitability of its own products.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772547128330 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Procaps Group is a Latin American pharmaceutical company specializing in complex drug delivery technologies (soft capsules) and contract manufacturing. It is a B2B/B2C pharma company. This chart shows how efficient and profitable their R&D (new formulations) and production lines are.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772547128369 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Procaps Group S.A. (PROC)
Procaps Group is a pharmaceutical company specializing in the development and production of soft gelatin capsules and other innovative dosage forms. This chart shows the productivity of its factories. The increase in revenue per employee indicates strong demand for its technologies from other pharmaceutical companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Procaps-Group-S.A.-PROC&v=1772547128438 "Sales chart per company employee Procaps Group S.A. (PROC)")
Sales per employee in the market segment - Pharma other
Procaps (PROC) is a Latin American pharmaceutical company specializing in softgels. They contract manufacture them for others (CDMO) and sell their own branded medications. This chart shows the combined revenue per employee across both divisions, measuring their production and commercial efficiency.
Sales per employee for the market as a whole
Procaps Group (PROC) is a Latin American pharmaceutical company specializing in the development and production of softgels and other drug forms, often for other companies (CDMOs). It is a B2B manufacturing business. This chart shows how efficiently the company utilizes its factories and personnel to produce pharmaceutical products.
Short shares by company, segment and market as a whole
Shares shorted by company Procaps Group S.A. (PROC)
Procaps Group is a Latin American pharmaceutical company that manufactures drugs under contract manufacturing (CDMO) and also has its own brands. The bearish sentiment shown in this chart may be related to investor concerns about economic and currency instability in its key Latin American markets.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Procaps-Group-S.A.-PROC&v=1772547128897 "Short Shares Chart for the Company Procaps Group S.A. (PROC)")
Shares shorted by market segment - Pharma other
Procaps Group (PROC) is an integrated pharmaceutical company in Latin America specializing in advanced drug delivery technologies, particularly soft gelatin capsules. This indicator measures the total volume of short positions across the entire specialty pharmaceutical sector. It indicates how skeptical investors are overall about growth in emerging markets or generic competition.
Shares shorted by the overall market
Procaps is a Latin American contract manufacturing organization (CDMO) for pharmaceutical companies. This chart illustrates the overall market pessimism. Investors fear that small biotech companies (CDMO clients) will lose R&D funding during the crisis. Added to this is the risk of emerging markets (EM), where capital is primarily fleeing.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Procaps Group S.A. (PROC)
Procaps Group is a Latin American pharmaceutical company specializing in the production of softgels and other complex dosage forms. This indicator tracks how investors view their growth in emerging markets, indicating "overbought" (above 70) or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Procaps-Group-S.A.-PROC&v=1772547129033 "RSI 14 indicator chart for the company's stock Procaps Group S.A. (PROC)")
RSI 14 Market Segment - Pharma other
Procaps Group is a Latin American pharmaceutical CDMO (contract manufacturer). They specialize in complex technologies, particularly the production of softgels. This chart reflects the overall sentiment in the pharmaceutical sector and helps assess how the market views the industry.
RSI 14 for the overall market
Procaps (PROC), a pharmaceutical company in Latin America, sees a dual risk in this chart: economics and geopolitics. In euphoria, investors are willing to invest in "growth" and in the region. In panic, capital flees Latin America, and (in a recession) demand for its services falls.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PROC (Procaps Group S.A.)
Procaps (PROC) is a large Latin American pharmaceutical company known for its softgel technology and contract manufacturing (CDMO). This chart shows the average 12-month forecast. It reflects analyst expectations for the growth of its drug portfolio in Latin America and the expansion of its B2B services for other pharmaceutical companies.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PROC-Procaps-Group-S.A.&v=1772547129121 "A chart showing analyst consensus forecasts for the expected stock price. PROC (Procaps Group S.A.)")
The difference between the consensus estimate and the actual stock price PROC (Procaps Group S.A.)
Procaps (PROC) is a softgel capsule company. It's a Latin American pharmaceutical company and a global leader in the development and manufacturing (CDMO) of softgel capsules. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe in their drug delivery technology and growth in the region.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PROC-Procaps-Group-S.A.&v=1772547129174 "A chart showing the difference between the consensus forecast and the actual stock price. PROC (Procaps Group S.A.)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Procaps is a Latin American CDMO (contract manufacturer) specializing in softgel capsules for the pharmaceutical and dietary supplement industries. This chart displays analysts' overall expectations for the *entire* pharmaceutical sector. It shows whether experts believe drug manufacturing outsourcing will grow in Latin America.
Analysts' consensus forecast for the overall market share price
Procaps (PROC) is a Latin American CDMO. The company produces softgels and other complex medications for Big Pharma and also sells its brands in Latin America. This chart shows the overall sentiment of global analysts. It reflects risk appetite for emerging markets and the stability of the healthcare sector.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Procaps Group S.A.
Procaps is a B2B pharmacy for Latin America. They don't do R&D; their specialty is manufacturing (CDMO) softgels and turnkey medications for other pharma companies (GSK, Pfizer) in Latin America. This chart is a barometer of the pharma industry in South America. It reflects their (stable) B2B business and their (risky) dependence on the (volatile) currencies of the region.
AKIMA Market Segment Index - Pharma other
Procaps Group (PROC) is a Latin American pharma company. They are a CDMO (contract manufacturer) with a unique selling point: they specialize in softgel capsules for other pharmaceutical companies. This chart compares their composite index to the sector, showing how their softgel niche is ahead of the competition.
The AKIM Index for the overall market
Procaps Group is a Latin American pharmaceutical company and a leader in softgel capsule technology. This chart, showing the average (global/US) market share, serves as a benchmark. It helps assess how PROC, a manufacturing and commercial player, compares to overall macroeconomic trends.
